Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

remune

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Objectives:Therapeutic HIV vaccination during the time of virologic suppression may delay or blunt viral load rebound after… Expand
2007
2007
Antibody responses against human leukocyte antigen (HLA) classes I and II were detected in HIV-1 infected individuals who… Expand
Highly Cited
2005
Highly Cited
2005
BACKGROUND Treatment strategies that would induce durable virological control of human immunodeficiency virus (HIV)-1 in the… Expand
  • figure 1
  • table 1
  • figure 3
  • table 2
  • table 3
2003
2003
The thymic output of patients receiving highly active antiretroviral therapy (HAART) was assessed by sjTREC (signal joint T cell… Expand
2001
2001
Abstract Purpose: By protecting and stimulating HIV-specific CD4 cell responses, treatment of primary HIV infection (PHI) with… Expand
2001
2001
Objective  We examined the activity of an HIV‐1 immunogen (Remune) on viral load, CD4 cells and HIV‐1 specific immunity. 
2000
2000
We examined HIV-1 specific memory helper T immune responses in chronically HIV-infected subjects who received an immune-based… Expand
1998
1998
The safety and immunogenicity of REMUNE, an HIV-specific immune based therapy for HIV infection, was evaluated in a cohort of 30… Expand
1997
1997
Lymphocyte proliferation responses to gp120-depleted HZ321 virus (clade A) antigen were compared to BAL human immunodeficiency… Expand
1997
1997
OBJECTIVE To measure beta-chemokine and cytokine production in HIV-1-infected subjects undergoing treatment with HIV-1 immunogen… Expand